Notice of Intent to Award to Sole Source - FSE On-Site Annual Preventative Maintenance

The Centers for Disease Control and Prevention (CDC) intends to award a sole source contract to CEPHEID for the FSE On-Site Annual Preventative Maintenance of the Cepheid GeneXpert DX system. The system is used for rapid detection and analysis of carbapenemase gene markers from rectal swab specimens and wastewater samples in support of public health testing activities. The contract is being awarded due to the proprietary nature of the GeneXpert DX platform, including manufacturer-specific components, software, maintenance requirements, and warranty conditions. • The contract is for the maintenance and support services of the existing equipment configuration. • The GeneXpert DX system has been integrated into the existing laboratory workflow and supports continuity of operations, surge testing capabilities, and ongoing Healthcare Wastewater sampling efforts. • The system is also used to support comparative analysis against standard PCR testing methodologies. • The Government conducted market research to identify potential sources capable of supporting the current system, and responses are being requested from vendors authorized to provide maintenance and support services for the Cepheid GeneXpert DX platform.